Cargando…
Stem Cell Therapy for Diabetes: Beta Cells versus Pancreatic Progenitors
Diabetes mellitus (DM) is one of the most prevalent metabolic disorders. In order to replace the function of the destroyed pancreatic beta cells in diabetes, islet transplantation is the most widely practiced treatment. However, it has several limitations. As an alternative approach, human pluripote...
Autores principales: | Memon, Bushra, Abdelalim, Essam M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072676/ https://www.ncbi.nlm.nih.gov/pubmed/31979403 http://dx.doi.org/10.3390/cells9020283 |
Ejemplares similares
-
Toward Precision Medicine with Human Pluripotent Stem Cells for Diabetes
por: Memon, Bushra, et al.
Publicado: (2022) -
Differentiation of human pluripotent stem cells into two distinct NKX6.1 populations of pancreatic progenitors
por: Aigha, Idil I., et al.
Publicado: (2018) -
Enhanced differentiation of human pluripotent stem cells into pancreatic progenitors co-expressing PDX1 and NKX6.1
por: Memon, Bushra, et al.
Publicado: (2018) -
Correction to: Enhanced differentiation of human pluripotent stem cells into pancreatic progenitors co-expressing PDX1 and NKX6.1
por: Memon, Bushra, et al.
Publicado: (2018) -
ACE2 function in the pancreatic islet: Implications for relationship between SARS‐CoV‐2 and diabetes
por: Memon, Bushra, et al.
Publicado: (2021)